FdaApplication

NDA 022217

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVARTIS PHARMACEUTICALS CORP
application_typeNDA
approval_date2009-09-16

Products (2)

ProductActive ingredientStrengthDosage form
VALTURNAALISKIREN HEMIFUMARATE; VALSARTANEQ 150MG BASE;160MGTABLET;ORAL
VALTURNAALISKIREN HEMIFUMARATE; VALSARTANEQ 300MG BASE;320MGTABLET;ORAL

2 products